Last reviewed · How we verify

NCT06932939

Comparison of CAMBRA123 and AAPD (CAT) for Caries Risk in Egyptian Children

Not yet recruiting Last updated 20 April 2025
What this trial tests

trial in Caries Experience in 376 participants. Not yet recruiting.

Timeline
1 June 2025
Primary endpoint
1 July 2025
1 July 2025

Quick facts

Lead sponsorCairo University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment376
Start date1 June 2025
Primary completion1 July 2025
Estimated completion1 July 2025
Sites1 location across Egypt

Conditions studied

Sponsor

Cairo University

Who can join

Adults 3 to 6, any sex, with Caries Experience. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study goal is to compare two indices in Egyptian children aged 3-6 years in caries detection and time needed for assessment which will contribute to variable data for pediatric oral health assessment locally and globally.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06932939.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing